John S. Goff

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Endoscopic Sclerotherapy as Compared with Endoscopic Ligation for Bleeding Esophageal Varices

Greg V. Stiegmann, John S. Goff, Patrice A. Michaletz-Onody et al. · New England Journal of Medicine · 1992 · 698 citations

Risk Factors for Post-ERCP Pancreatitis: A Prospective Multicenter Study

Chi-Liang Cheng, Stuart Sherman, James L. Watkins et al. · The American Journal of Gastroenterology · 2006 · 659 citations · Full text

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

William J. Sandborn, Subrata Ghosh, Julián Panés et al. · Clinical Gastroenterology and Hepatology · 2014 · 295 citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +9